Perceptive Advisors LLC Axsome Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

$44.8 Billion
Q3 2025

A detailed history of Perceptive Advisors LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 148,900 shares of AXSM stock, worth $20.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

148,900

Previous 198,534 25.0%

Holding current value

$20.8 Million

Previous $20.7 Million 12.74%

% of portfolio

0.04%

Previous 0.91%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$100.39 - $129.29 $4.98 Million - $6.42 Million	-49,634 Reduced 25.0%	148,900 $18.1 Million
Q2 2025 Aug 14, 2025	SELL	$95.65 - $116.49 $15 Million - $18.2 Million	-156,573 Reduced 44.09%	198,534 $20.7 Million
Q1 2025 May 15, 2025	SELL	$80.05 - $137.75 $24.7 Million - $42.6 Million	-308,967 Reduced 46.53%	355,107 $41.4 Million
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $9.87 Million - $11.9 Million	-118,770 Reduced 15.17%	664,074 $56.2 Million
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $25.6 Million - $31 Million	323,733 Added 70.51%	782,844 $70.3 Million

Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $42.5 Million - $52 Million	-646,230 Reduced 58.46%	459,111 $37 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $4.67 Million - $6.57 Million	67,322 Added 6.49%	1,105,341 $88.2 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $31.9 Million - $46.5 Million	556,370 Added 115.51%	1,038,019 $82.6 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $14.6 Million - $17.3 Million	210,156 Added 77.41%	481,649 $33.7 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $15.9 Million - $24.5 Million	271,493 New	271,493 $19.5 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $1.91 Million - $3.33 Million	-80,420 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $9.43 Million - $32.3 Million	-473,488 Reduced 85.48%	80,420 $2.65 Million
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $28 Million - $40.7 Million	553,908 New	553,908 $37.4 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $3.42 Million - $4.29 Million	-50,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $2.49 Million - $4.93 Million	50,000 New	50,000 $4.11 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $900,318 - $5.72 Million	-53,879 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $141,701 - $880,382	53,879 New	53,879 $767,000

Others Institutions Holding AXSM

# of Institutions

414

Shares Held

36.8M

Call Options Held

752K

Put Options Held

567K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Axsome Therapeutics, Inc. Transaction History